SkyQuest Technology Group has recently published a comprehensive Orthobiologics Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. Orthobiologics comprises a wide range of products that improve healing of musculoskeletal conditions and injuries. This comprises stem cells, bone grafts, PRP (plasma-rich-platelet), and several other regenerative treatments. The global orthobiologics market is considerably impacted by factors like increasing developments and advances in regenerative medicine therapies, growing senior population, and growing incidences of orthopedic procedures.
Global Orthobiologics Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 8.78 billion in 2024 to USD 13.79 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).
Nonetheless, a few restraints hampering the growth of the orthobiologics market include stringent approval processes, lack of standardization, and costly surgeries and treatments. Still, the market is anticipated to witness substantial growth over the estimated period owing to opportunities like expanding applications of orthobiologics, rising research and developments, and growing inclination towards personalized medicine.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/orthobiologics-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Orthobiologics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Orthobiologics Market is segmented by Product Type, Type, Application, End-user and region.
Based on Product Type, the market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone morphogenetic protein (BMP), Viscosupplementation, Synthetic bone substitutes and Stem cell therapy.
Based on Type, the market is segmented into Knee, Ankle, Hip, Wrist & Shoulder, Spine and Others.
Based on Application, the market is segmented into Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications.
Based on End-user, the market is segmented into Hospitals & Ambulatory Centers, Research & Academic Institute and Dental Clinics.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Orthobiologics Market – Regional Analysis:
Geographically, North America dominated the market in 2023 and is expected to lead over the forecast period owing to the presence of improved healthcare infrastructure, growing cases of musculoskeletal issues, and strong research and growing number of research and developments. North America brags about its developed healthcare infrastructure with easy access to superior technologies and well-trained professionals.
Regional growth is also impacted by the rising number of sports patients that report sports injuries and osteoarthritis issues. This majorly demands improved and innovative treatments. Furthermore, increasing amount of research and development fuels modernizations in orthobiologics, resulting in the emergence of novel therapies.
Europe is the fastest-growing region in the global orthobiologics market due to strong research and innovation, regulatory support, and the growing aging population. Europe is the leading center for several universities and research institutes that emphasize orthobiologics and regenerative medicines, which drives developments and innovations.
Top Market Players in Orthobiologics Market are:
Stryker Corporation (USA)
Medtronic plc (Ireland)
Zimmer Biomet Holdings, Inc. (USA)
DePuy Synthes (Johnson & Johnson) (USA)
Bioventus LLC (USA)
Arthrex, Inc. (USA)
NuVasive, Inc. (USA)
Orthofix International N.V. (Netherlands)
Globus Medical, Inc. (USA)
Kuros Biosciences AG (Switzerland)
Xtant Medical Holdings, Inc. (USA)
Harvest Technologies Corporation (USA)
Wright Medical Group N.V. (Netherlands)
Smith & Nephew plc (UK)
Bone Biologics Corp. (USA)
Sano Orthopedics (USA)
Orthobiologics Market Recent Developments:
In September 2024, Stryker introduced the addition of two novel products to its product line of Foot & Ankle. Ankle Truss System™ (ATS) and Osteotomy Truss System™ (OTS) lately acquired by 4WEB Medical. Stryker will present both the products at the AOFAS Annual Meeting in Canada.
In September 2024, Orthofix Medical Incorporation announced the introduction of fresh data aiding the use of the company’s branded (PEMF) Pulsed Electromagnetic Field simulation to accelerate fusion rates as an assistant to lumbar spine fusion procedure.
In November 2023, Smith+Nephew announced that it signed a contract to acquire CartiHeal. This acquisition supports Smith+Nephew’s strategy to invest behind its successful Sports Medicine Business. Also, the purchase will accompany their current knee repair product line with commercial specialization in high-growth biologics.
You may Also Like
https://issuu.com/skyquest-technology/docs/liquid_biopsy_market_revolutionizing_cancer_detec
https://issuu.com/skyquest-technology/docs/polycarbonate_market_performance_metrics_and_futur/s/84231083
Forward-Looking Insights
The Orthobiologics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email:
